Skip to main content
Have a personal or library account? Click to login
Colon specific delivery of budesonide based on triple coated pellets: in vitro/in vivo evaluation Cover

Colon specific delivery of budesonide based on triple coated pellets: in vitro/in vivo evaluation

Acta Pharmaceutica
Volume 62 (2012): Issue 3 (September 2012)
By: ,  ,  ,  ,  ,   and    
Open Access
|Nov 2012
References

References

  1. 1. D. C. Baumgart, Treatment of inflammatory bowel disease: A review of medical therapy,(2008) 354-377; DOI: 10.3748/wjg.14.354.
    Open DOISearch in Google Scholar
  2. 2. U. Klotz and M. Schwab, Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease,(2005) 267-279; DOI: 10.1016/j.addr.2006.09.011.
    Open DOISearch in Google Scholar
  3. 3. M. Jiménez and A. S. Peña, Budesonide for ulcerative colitis,(2006) 362-373; DOI: 1130-0108/2006/98/5/362-373.
    Search in Google Scholar
  4. 4. K. Dilger, M. Alberer, A. Busch, A. Enninger, R. Behrens, S. Koletzko, M. Stern, C. Beckmann and C. H. Gleiter, Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn’s disease,.(2006) 387-395; DOI: 10.1111/j.1365-2036.2006. 02771.x.
    Search in Google Scholar
  5. 5. J. Seidegård, L. Nyberg and O. Borgå, Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole,.(2008) 264-70; DOI: 10.1016/j.ejps.2008.07.005.
    Open DOISearch in Google Scholar
  6. 6. L. F. Asghar and S. Chandran, Multiparticulate formulation approach to colon specific drug delivery: current perspectives,(2006) 327-338.
    Search in Google Scholar
  7. 7. Y. Krishnamachari, P. Madan and S. Lin, Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon,(2007) 238-47; DOI: 10.1016/j.ijpharm.2007.02.015.
    Open DOISearch in Google Scholar
  8. 8. A. Makhlof, Y. Tozuka and H. Takeuchi, pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model,(2009) 1-8; DOI: 10.1016/j.ejpb.2008.12.013.
    Open DOISearch in Google Scholar
  9. 9, USP Convention, Rockville 2002.
    Search in Google Scholar
  10. 10. J. Varshosaz, J. Emami, N. Tavakoli, A. Fassihi, M. Minaiyan, F. Ahmadi and F. Dorkoosh, Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis,(2009) 69-76; DOI: 10.1016/j.ijpharm.2008.08.034.
    Open DOISearch in Google Scholar
  11. 11. J. Ding, X. Wang, T. Zhang, Q. Li and M. Luo, Optimization of RP-HPLC analysis of low molecular weight organic acids in soil,.(2006) 99-111; DOI: 10.1080/10826070500363050.
    Open DOISearch in Google Scholar
  12. 12. T. Higuchi, Mechanism of sustained-action medication,(1963) 1145-1149; DOI: 10.1002/jps. 2600521210.
    Search in Google Scholar
  13. 13. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers,(1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.
    Open DOISearch in Google Scholar
  14. 14. N. A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers,.(1985) 110-111.
    Search in Google Scholar
  15. 15. P. Costa and J. M. Sonsa Lobo, Modelling and comparison of dissolution profiles,(2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.
    Open DOISearch in Google Scholar
  16. 16. G. P. Morris, P. L. Beck, M. S. Herridge, W. T. Depew, M. R. Szewczuk and J. L. Wallace, Hapten-induced model of colonic inflammation and ulceration in the rat colon,(1989) 795-803.
    Open DOISearch in Google Scholar
  17. 17. S. Choudhary, A. Keshavarzian, S. Yong, M. Wade, S. Bocckino, B. J. Day and A. Banan, Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats,(2001) 2222-2230; DOI: 10.1023/A: 1011975218006.
    Search in Google Scholar
  18. 18. S. Y. Zhou, Q. B. Mei, L. Liu, X. Guo, B. S. Qiu, D. H. Zhao and C. H. Cho, Delivery of glucocorticoid conjugates in rat gastrointestinal tract and its treatment for ulcerative colitis,.(2001) 761-764.
    Search in Google Scholar
  19. 19. J. L. Wallace and C. M. Keenan, An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis,.(1990) 527-534.
    Search in Google Scholar
  20. 20. C. B. Appleyard and J. L. Wallace, Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs,(1995) 119-125.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10007-012-0025-y | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English, Croatian, Slovenian
Page range: 341 - 356
Published on: Nov 6, 2012
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
colon delivery,
three layered pellets,
Eudragit E,
budesonide,
HPMC AS,
HPMC
Related subjects:
Pharmacy,
Pharmacy, other

© 2012 Jaleh Varshosaz, Jaber Emami, Naser Tavakoli, Mohsen Minaiyan, Nakisa Rahmani, Farid Dorkoosh, Parvin Mahzouni, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 62 (2012): Issue 3 (September 2012)
Previous article
Next article